INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 114.90% for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2025-04-30
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2023-03-31 was 114.90%, a 1.50% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2022-03-31 was 113.20%.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2023 was 114.90%, a 0.26% increase from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2022 was 114.60%, a 8.32% decline from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2021 was 125.00%, a 2.34% decline from fiscal 2020.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2020 was 128.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | 114.90% 10-K · filed 2025-04-30 | |||||
| 2023-09-30 | 114.90% 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | 114.90% 10-Q/A · filed 2024-11-19 | |||||
| 2023-03-31 | 114.90% 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | 114.60% 10-K/A · filed 2024-11-19 | |||||
| 2022-09-30 | 113.20% 10-Q · filed 2023-11-13 | 113.00% 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 113.20% 10-Q · filed 2023-08-14 | 113.00% 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | 113.20% 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | 125.00% 10-K · filed 2023-04-17 | |||||
| 2021-09-30 | 125.00% 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 125.00% 10-Q · filed 2022-08-15 | |||||
| 2020-12-31 | 128.00% 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | 128.00% 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | 128.00% 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |